One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editor's Choice – John Ingram – May 2023
doi : 10.1093/bjd/ljad090
Editor's Choice – John Ingram – May 2023
The BJD’s approach to global health and equity in publishing: adding author reflexivity statements
Esther E Freeman, Valeska Padovese, Archana Singal, Rie Yotsu, Linda Oyesiku, Alaina J James, Francisco G Bravo, Anisa Mosam
doi : 10.1093/bjd/ljad058
Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor–patient communication in avoiding drug discontinuation
Mario Valenti, Antonio Costanzo
doi : 10.1093/bjd/ljad014
A milestone reached in the standardization of lichen sclerosus trial outcomes
Linnea Thorlacius, Murad Alam
doi : 10.1093/bjd/ljad025
In search of therapeutic biomarkers to interleukin-23 antagonism in hidradenitis suppurativa
John W Frew
doi : 10.1093/bjd/ljad027
Conventional therapy in psoriasis. Lost in translation?
Jose-Manuel Carrascosa
doi : 10.1093/bjd/ljad030
Hope for a new therapy for hidradenitis suppurativa: blocking of granulocyte colony-stimulating factor receptor
Kerstin Wolk
doi : 10.1093/bjd/ljad056
The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: a narrative review
Pedro Mendes-Bastos, Antonio Martorell, Vincenzo Bettoli, António P Matos, Elisa Muscianisi, Ximena Wortsman
doi : 10.1093/bjd/ljad028
Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study
Koen Dudink, Klasiena Bouwman, Yanqing Chen, Samuel E DePrimo, Ernesto J Munoz-Elias, Pim Aarts, Renske Schappin, Edwin F Florencia, Bennie van Heeswijk, Lisette M Prens, Hessel H van der Zee, Errol P Prens, Kelsey R van Straalen, Barbara Horváth
doi : 10.1093/bjd/ljad010
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey
Sophia Quirke-McFarlane, John Weinman, Emma S Cook, Zenas Z N Yiu, Nick Dand, Sinead M Langan, Katie Bechman, Teresa Tsakok, Kayleigh J Mason, Helen McAteer, Freya Meynell, Bolaji Coker, Alexandra Vincent, Dominic Urmston, Amber Vesty, Jade Kelly, Camille Lancelot, Lucy Moorhead, Ines A Barbosa, Herve Bachelez, Francesca Capon, Claudia R Contreras, Claudia De La Cruz, Paola Di Meglio, Paolo Gisondi, Denis Jullien, Jo Lambert, Luigi Naldi, LluÃs Puig, Phyllis Spuls, Tiago Torres, Richard B Warren, Hoseah Waweru, James B Galloway, Christopher E M Griffiths, Jonathan N Barker, Sam Norton, Catherine H Smith, Satveer K Mahil, the PsoProtect study group
doi : 10.1093/bjd/ljac144
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR
Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, Philip J Hampton, Nick J Reynolds, Caroline M Owen, Anthony Bewley, Philip M Laws, Richard B Warren, Mark Lunt, Catherine H Smith, Christopher E M Grif�ths, BADBIR Study Group
doi : 10.1093/bjd/ljad004
Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement
Rosalind C Simpson, Gudula Kirtschig, Amanda Selk, Suzanne von Seitzberg, Gitte Vittrup, Ione Bissonnette, Jan Kottner, Jaclyn Lanthier, Chris Stanton, David Foster, Martin Promm, Angelo Augenti, Stefano Lauretti, Kim S Thomas, the Core Outcomes for Research in Lichen Sclerosus (CORALS) initiative steering group
doi : 10.1093/bjd/ljac145
CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa
Cristina Gamell, Aleksandra Bankovacki, Karen Scalzo-Inguanti, Bradley Sedgmen, Monther Alhamdoosh, Emma Gail, Lydia Turkovic, Christine Millar, Laura Johnson, Michelle Wahlsten, Jim Richter, Jared Schuster, Allison Dyson, Jenny Nicolopoulos, George Varigos, Milica Ng, Nick Wilson, Judith Field, Johannes S Kern, Lisa M Lindqvist
doi : 10.1093/bjd/ljad013
British Journal of Dermatology, Volume 188, Issue 5, May 2023, Pages 636–648
Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab
Yuemeng Wu, Chaoying Gu, Shangshang Wang, Huibin Yin, Zhuoqiong Qiu, Yang Luo, Zheng Li, Ce Wang, Xu Yao, Wei Li
doi : 10.1093/bjd/ljad032
Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study
Amanda Kvist-Hansen, Laura Pérez-Alós, Rownaq Fares Al-Sofi, Line Dam Heftdal, Sebastian Rask Hamm, Dina Leth Møller, Mia Marie Pries-Heje, Kamille Fogh, Cecilie Bo Hansen, Rasmus Bo Hasselbalch, Johannes Roth Madsen, Jose Juan Almagro Armenteros, Ruth Frikke-Schmidt, Linda Hilsted, Erik Sørensen, Sisse Rye Ostrowski, Henning Bundgaard, Susanne Dam Nielsen, Kasper Iversen, Claus Zachariae, Peter Garred, Lone Skov
doi : 10.1093/bjd/ljad023
No association between physical activity and primary melanoma thickness in a cohort of Norwegian women
Flavie Perrier, Trude E Robsahm, Reza Ghiasvand, Kristin B Borch, Tonje Braaten, Elisabete Weiderpass, Corina S Rueegg, Adele C Green, Marit B Veierød
doi : 10.1093/bjd/ljac136
Initial validation of the Hidradenitis Suppurativa Quality of Life tool in a clinical trial setting
Leandro L Santos, Zhaoyin Zhu, Kurt Brown, Joslyn S Kirby
doi : 10.1093/bjd/ljac141
The association between pilonidal sinus disease and hidradenitis suppurativa: a systematic review and meta-analysis
Kirsty J L Wark, Samuel A Der Sarkissian, Artiene Tatian, Jane Woods, Geoffrey D Cains
doi : 10.1093/bjd/ljac166
Detection of extensive host–virus DNA hybrids in human polyomavirus 7-associated pruritic rash
Gabriel J Starrett, Jae W Lee, Subhajit Chatterjee, Jaroslaw J Jedrych
doi : 10.1093/bjd/ljad002
Long-term clinical trials of biologics in plaque psoriasis demonstrate heterogeneous study designs
Chloé Grolleau, Laurence Le Cleach, Jason Shourick, Emilie Sbidian, Sivem Afach
doi : 10.1093/bjd/ljac142
Successful dose reduction of dupilumab in atopic dermatitis
Michael R Ardern-Jones, Emily E Buchanan, Samba Njungu, Daniel O’Driscoll
doi : 10.1093/bjd/ljad011
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma
Alessandro Borghi, Lucilla D’Abundo, Cristian Bassi, Laura Lupini, Valentina Tagliatti, Pierantonia Zedde, Giovanni Lanza, Roberta Gafà , Massimo Negrini, Monica Corazza
doi : 10.1093/bjd/ljad024
Less confident, successful and happy: patients with post-acne hyperpigmentation are stigmatized
Barbara Schuster, Julia Gallinger, Wolfgang G Philipp-Dormston, Matthäus Vasel, Alison M Layton
doi : 10.1093/bjd/ljad026
Polymerase-δ-deficiency as a novel cause of inborn cancer predisposition associated with human papillomavirus infection
Johanna Strobl, Bettina Huber, Raul Jimenez Heredia, Reinhard Kirnbauer, Kaan Boztug, Georg Stary
doi : 10.1093/bjd/ljad021
Is it time we changed the way we manage melanoma in situ of the trunk and limbs?
Hayley Smith, Walayat Hussain
doi : 10.1093/bjd/ljad031
The rise in thick melanomas: can early detection reduce the burden?
Catherine M Olsen, Nirmala Pandeya, David C Whiteman
doi : 10.1093/bjd/ljad034
Cross-cultural adaptation and psychometric properties of the Brazilian Portuguese version of the Impact of Neurofibromatosis type 1 on Quality of Life (INF1-QoL) questionnaire
Natália P Bicudo, Carla Maria Ramos Germano, Lucimar R S de Avó, Rosalie E Ferner, Débora G Melo
doi : 10.1093/bjd/ljad037
Local cutaneous refractoriness to sun exposure following omalizumab injections in solar urticaria
Sheila M McSweeney, Keyna Bintcliffe, Hiva Fassihi, Robert Sarkany, Chris Rutkowski
doi : 10.1093/bjd/ljad012
The real-world effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for treating moderate-to-severe psoriasis
doi : 10.1093/bjd/ljad092
Serum biomarker analysis to identify subtypes of atopic dermatitis in China and to help with predicting the effectiveness of treatment with dupilumab
doi : 10.1093/bjd/ljad091
Immunity 6 months after COVID-19 vaccination in patients with psoriasis treated with immunomodulatory drugs
doi : 10.1093/bjd/ljad094
